AMANDA HUNDLEY: Open Payments
NPI 1811249733 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 39 payments from 14 companies in 2025. Trend: 2023 $683 · 2024 $992 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $204 |
| Novartis Pharmaceuticals Corporation | 3 | $91 |
| Celgene Corporation | 4 | $86 |
| ABBVIE INC. | 4 | $83 |
| Janssen Biotech, Inc. | 4 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $42 |
Products named: REBLOZYL, XTANDI, BOSULIF, PLUVICTO, VERZENIO, IBRANCE, TALVEY, OJJAARA.
Industry payments across VA — which companies pay providers there.
